Table 1 Act Scores, Pulmonary Function and Inflammatory Parameters of the Study Patients at the Baseline and Follow Up Visits
Baseline (n = 83) | 3rd month (n = 83) | p* | |
|---|---|---|---|
ACT score (mean ± SD) | 18.98 ± 4.59 | 19.65 ± 4.11 | 0.164 |
Control of asthma, n (%) | 0.779 | ||
Totally controlled | 8 (10) | 10 (12) | |
Partially controlled | 36 (43) | 39 (47) | |
Uncontrolled | 39 (47) | 34 (41) | |
FEV1 (L) (mean ± SD) | 2.59 ± 0.62 | 2.65 ± 0.60 | 0.162 |
FEV1 (%) (mean ± SD) | 93.9 ± 13.7 | 93.0 ± 15.8 | 0.968 |
FEV1/FVC (%) (mean ± SD) | 78.2 ± 6.9 | 77.7 ± 7.1 | 0.387 |
MBPT positivity, n (%) | 49 (59) | 37 (45) | 0.029 |
FeNO (ppb), median (1st and 3rd quartiles) | 15 (11-26) | 14 (11-21) | 0.025 |
Elevated induced sputum eosinophil (> 3%), n (%) | 11/47 (23) | 9/30 (30%) | 0.791 |
Induced sputum neutrophil (%), median (1st and 3rd quartiles) | 32 (11-50) | 34 (18-56) | 0.241 |